Subtopic Deep Dive
Health Economics of Radiotherapy
Research Guide
What is Health Economics of Radiotherapy?
Health Economics of Radiotherapy evaluates the cost-effectiveness, resource utilization, and financing models for radiotherapy delivery in cancer care.
This subtopic analyzes incremental cost-effectiveness ratios, budget impacts, and staffing needs across global regions and income levels. Key studies include Zubizarreta et al. (2016) on global radiotherapy costs (165 citations) and Lievens et al. (2014) on European staffing (100 citations). Over 20 papers from ESTRO-HERO project address equipment and personnel guidelines.
Why It Matters
Economic analyses guide resource allocation for radiotherapy in low-income settings, as shown in Zubizarreta et al. (2016) estimating needs by income level. Lievens and Grau (2012) highlight radiotherapy's role for over 50% of cancer patients, informing value-based financing. Prescott et al. (2007) demonstrate cost savings from omitting radiotherapy in low-risk breast cancer cases (111 citations), supporting sustainable scaling.
Key Research Challenges
Global Access Disparities
Radiotherapy access varies by region and income, with shortages in low-resource areas. Zubizarreta et al. (2016) quantify costs and needs across geographies. Lievens et al. (2021) outline strategies for equitable distribution.
Staffing and Equipment Costs
Optimal staffing and equipment benchmarks exceed availability in many countries. Lievens et al. (2014) report European figures aligning with QUARTS recommendations. Dunscombe et al. (2014) provide guidelines linking metrics to needs (76 citations).
Cost-Effectiveness Modeling
Accurate incremental cost ratios require population-based data on incidence and stage. Borràs et al. (2015) develop methodology for optimal utilization (138 citations). Prescott et al. (2007) trial shows quality-of-life gains from reduced treatment.
Essential Papers
GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists
S. V. S. Deo, Jyoti Sharma, Sunil Kumar · 2022 · Annals of Surgical Oncology · 439 citations
Analysis of Global Radiotherapy Needs and Costs by Geographic Region and Income Level
Eduardo Zubizarreta, Jacob Van Dyk, Yolande Lievens · 2016 · Clinical Oncology · 165 citations
Recent years have seen various reviews on the lack of access to radiotherapy often based on geographic regions of the world such as Africa, Asia Pacific, Europe, Latin America and North America. Co...
The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project
Josep M. Borràs, Michael Bartoň, Cai Grau et al. · 2015 · Radiotherapy and Oncology · 138 citations
Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?
M Thompson, Philip Poortmans, Anthony J. Chalmers et al. · 2018 · British Journal of Cancer · 123 citations
Global Radiotherapy: Current Status and Future Directions—White Paper
May Abdel–Wahab, Soehartati Gondhowiardjo, Arthur Accioly Rosa et al. · 2021 · JCO Global Oncology · 122 citations
Recognizing the increase in cancer incidence globally and the need for effective cancer control interventions, several organizations, professional bodies, and international institutions have propos...
The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource‐Stratified Phased Implementation: Methods and overview
Catherine Duggan, Allison Dvaladze, Anne F. Rositch et al. · 2020 · Cancer · 122 citations
Background The Breast Health Global Initiative (BHGI) established a series of resource‐stratified, evidence‐based guidelines to address breast cancer control in the context of available resources. ...
A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial
R. Prescott, I. Kunkler, Letitia Williams et al. · 2007 · Health Technology Assessment · 111 citations
Although there are no differences in overall quality of life scores between the patients treated with and without radiotherapy, there are several dimensions that exhibit significant advantage to th...
Reading Guide
Foundational Papers
Start with Lievens and Grau (2012) introducing ESTRO HERO project for radiotherapy economics context (79 citations), then Prescott et al. (2007) PRIME trial for cost-effectiveness evidence in breast cancer (111 citations), followed by Lievens et al. (2014) staffing survey (100 citations).
Recent Advances
Study Zubizarreta et al. (2016) on global needs (165 citations), Lievens et al. (2021) white paper on directions (122 citations), and Duggan et al. (2020) on resource-stratified breast guidelines (122 citations).
Core Methods
Core techniques: ESTRO-HERO surveys for staffing/equipment (Lievens 2014, Dunscombe 2014), population incidence-stage modeling (Borràs 2015), and RCT-based ICER/QoL analysis (Prescott 2007).
How PapersFlow Helps You Research Health Economics of Radiotherapy
Discover & Search
Research Agent uses searchPapers and exaSearch to find ESTRO-HERO papers like Zubizarreta et al. (2016), then citationGraph reveals clusters on global costs connected to Lievens et al. (2014) staffing data, while findSimilarPapers uncovers related works on resource-stratified guidelines.
Analyze & Verify
Analysis Agent applies readPaperContent to extract cost models from Zubizarreta et al. (2016), verifies claims with CoVe against Prescott et al. (2007) trial data, and runs PythonAnalysis with pandas to compute budget impacts from staffing figures in Lievens et al. (2014), graded via GRADE for evidence quality in economic evaluations.
Synthesize & Write
Synthesis Agent detects gaps in low-income radiotherapy financing from Lievens and Grau (2012), flags contradictions in access metrics, and uses exportMermaid for cost-flow diagrams; Writing Agent employs latexEditText, latexSyncCitations for ESTRO papers, and latexCompile to generate policy briefs.
Use Cases
"Model budget impact of radiotherapy staffing shortages in Europe using 2014 data"
Research Agent → searchPapers('ESTRO-HERO staffing') → Analysis Agent → readPaperContent(Lievens 2014) → runPythonAnalysis(pandas on personnel figures) → matplotlib plot of costs per QUARTS benchmarks.
"Write LaTeX report on cost-effectiveness of PRIME trial radiotherapy omission"
Research Agent → citationGraph(PRIME trial) → Synthesis Agent → gap detection → Writing Agent → latexEditText(draft) → latexSyncCitations(Prescott 2007) → latexCompile(HTA report with tables).
"Find code for global radiotherapy cost simulations"
Research Agent → searchPapers('radiotherapy cost model code') → Code Discovery → paperExtractUrls → paperFindGithubRepo(Zubizarreta-style models) → githubRepoInspect → runPythonAnalysis on extracted scripts for income-level projections.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ ESTRO-HERO papers: searchPapers → citationGraph → readPaperContent → GRADE grading → structured economic summary report. DeepScan applies 7-step analysis with CoVe checkpoints to verify Zubizarreta et al. (2016) cost estimates against regional data. Theorizer generates financing models from Lievens et al. (2012-2021) corpus, hypothesizing resource-stratified interventions.
Frequently Asked Questions
What defines Health Economics of Radiotherapy?
It assesses cost-effectiveness, staffing, and financing for radiotherapy in oncology, including incremental cost ratios and budget impacts across income levels.
What are key methods used?
Methods include population-based utilization analysis (Borràs et al., 2015), staffing surveys (Lievens et al., 2014), and randomized trials like PRIME (Prescott et al., 2007) for cost-QoL trade-offs.
What are major papers?
Top papers: Zubizarreta et al. (2016, 165 citations) on global costs; Lievens et al. (2014, 100 citations) on staffing; Prescott et al. (2007, 111 citations) on breast cancer trial.
What open problems exist?
Challenges include modeling costs for emerging technologies in low-income regions and scaling staffing per Dunscombe et al. (2014) guidelines amid rising cancer incidence.
Research Advances in Oncology and Radiotherapy with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Health Economics of Radiotherapy with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers